Pfizer: drugmaker puts Covid cash to work - Financial Times
May 10, 2022 · The US drugmaker on Tuesday agreed to buy migraine treatment developer Biohaven Pharmaceuticals for $11.6bn in cash. At $148.5 a share, the offer represents a 79 …
OFF
Pfizer: Drugmaker Puts Covid Cash To Work - Financial Times
1 week from now
May 10, 2022 · The US drugmaker on Tuesday agreed to buy migraine treatment developer Biohaven Pharmaceuticals for $11.6bn in cash. At $148.5 a share, the offer represents a 79 …
ft.com
OFF
Pfizer To Buy Biotech Group BioHaven For €11 Billion
1 week from now
Tue May 10 2022 - 12:44. US pharmaceuticals group Pfizer has agreed to buy biotechnology group BioHaven for more than $11.8 billion (€11.1 billion) in cash, in what will be its biggest …
irishtimes.com
OFF
Pfizer Completes Acquisition Of Biohaven Pharmaceuticals
1 week from now
Oct 3, 2022 · Pfizer acquired all of the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, for a total transaction consideration of approximately …
pfizer.com
OFF
Pfizer To Buy Biotech Group Biohaven For $11.6bn
1 week from now
US pharmaceutical group’s biggest deal in more than 5 years comes as sales of its Covid vaccine are set to fall
dur.ac.uk
OFF
Pfizer To Buy Rest Of Biohaven For $11.6 Billion - WSJ
1 week from now
May 10, 2022 · Pfizer Inc. PFE 0.55% agreed to buy the rest of Biohaven Pharmaceutical Holding Co. BHVN 0.33% for about $11.6 billion, deploying its pile of cash earned from Covid-19 sales …
wsj.com
OFF
Pfizer To Buy Migraine Drugmaker Biohaven In $11.6-billion Deal
1 week from now
May 10, 2022 · Pfizer said it will acquire all the outstanding shares of Biohaven that it does not already own for $148.50 per share in cash, a 78.6% premium to Biohaven’s last closing price. …
financialpost.com
OFF
Pfizer To Buy Biohaven Pharmaceutical In $11.6 Bln Deal
1 week from now
May 10 (Reuters) - Pfizer Inc PFE.N said on Tuesday it will buy migraine drug maker Biohaven Pharmaceutical Holding Company Ltd BHVN.N for about $11.6 billion in cash. Pfizer will …
nasdaq.com
OFF
Pfizer Acquires Biohaven Pharmaceutical For $11.6 Billion In Cash
1 week from now
May 24, 2022 · Pfizer Inc. and Biohaven Pharmaceutical announced that Pfizer will acquire Biohaven for $11.6 billion in cash after years of collaborative drug development, improving …
techtarget.com
OFF
Pfizer To Buy Biotech Group Biohaven For US$11.6 Billion
1 week from now
Pfizer has agreed to buy US biotech Biohaven Pharmaceuticals for US$11.6 billion ($18.4b), striking its biggest deal in more than five years as the pharma company bolsters its pipeline of …
nzherald.co.nz
OFF
Pfizer To Pay $11.6 Bln For Biohaven To Tap Migraine Market
1 week from now
Show more companies. May 10 (Reuters) - Pfizer Inc (PFE.N) said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co (BHVN.N), making a big bet on its ability to …
reuters.com
OFF
Pfizer To Acquire Biohaven Pharmaceutical For $11.6 Billion
1 week from now
May 10, 2022 · Pfizer Inc. said it will acquire Biohaven Pharmaceutical Holding Co. for $11.6 billion in cash to gain an approved treatment for migraine headaches. Pfizer will pay $148.50 a …
bloomberg.com
OFF
Pfizer To Buy Biohaven Pharmaceuticals For $11.6 Billion
1 week from now
Shares of Biohaven, which makes the migraine medication Nurtec ODT, soar following the announcement. ... Biotech and Pharma; Pfizer to Buy Biohaven Pharmaceuticals for $11.6 …
barrons.com
OFF
Pfizer To Buy Biohaven For $11.6 Billion | C&EN Global Enterprise
1 week from now
May 16, 2022 · Seeking Nurtec, a pill approved to treat and prevent migraine in adults, Pfizer has agreed to acquire its maker, Biohaven Pharmaceuticals, in a cash deal valued at $11.6 billion. …
acs.org
OFF
Pfizer To Pay $11.6 Billion For Biohaven To Tap Migraine Market
1 week from now
Pfizer Inc said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co, making a big bet on its ability to boost sales of the top-selling pill in a new class of migraine …
yahoo.com
OFF
Pfizer's $11.6 Bln Biohaven Buy Could Spark More Biotech Deals
1 week from now
May 11, 2022 · Pfizer offered a 78.6% premium, or $148.50 per Biohaven share, but that was below the $151.51 price Biohaven shares traded at in October before the months-long selloff …
reuters.com
OFF
Pfizer's $11.6 Bn Biohaven Buy Could Spark More Biotech Deals
1 week from now
May 11, 2022 · Pfizer Inc's $11.6 billion deal for migraine specialist Biohaven Pharmaceutical has kindled expectations on Wall Street that it may usher in more buyouts as cash-flush …
indiatimes.com
OFF
Pfizer In Talks To Buy Global Blood Therapeutics For Roughly $5bn
1 week from now
Aug 5, 2022 · Pfizer in May agreed a $11.6bn deal to buy US biotech Biohaven Pharmaceuticals, which is developing migraine treatments. It also recently completed a $6.7bn deal to buy …
ft.com
FAQs about Pfizer: drugmaker puts Covid cash to work - Financial Times Coupon?
Will Pfizer buy Biohaven Pharmaceuticals?
Will Pfizer buy migraine drug maker Biohaven?
Will Pfizer's $11.6 billion Biohaven deal usher in more buyouts?
Does Pfizer owe Biohaven royalties?
How much will Biohaven sell in a year?
What happened to Biohaven pharmaceutical?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
